Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group.

Di Leo, A

Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group. [electronic resource] - American journal of clinical oncology Jun 1995 - 239-44 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

0277-3732

10.1097/00000421-199506000-00011 doi


Aged
Ambulatory Care
Bone Neoplasms--drug therapy
Drug Synergism
Drug Therapy, Combination
Epirubicin--administration & dosage
Heart Failure--chemically induced
Humans
Male
Medroxyprogesterone Acetate--administration & dosage
Middle Aged
Neoplasms, Hormone-Dependent--drug therapy
Pain--drug therapy
Pain Measurement
Palliative Care
Prostatic Neoplasms--drug therapy
Survival Analysis